Tin tức & Cập nhật
Xem bài viết Nhi khoa
Xem
Chỉ hiển thị Multimedia

Mavacamten reduces blood flow obstruction in adolescents with HCM
14 Apr 2026
bởiStephen Padilla
Treatment with mavacamten, compared with placebo, results in significantly greater reduction in left ventricular outflow tract (LVOT) obstruction over 28 weeks among adolescent patients with obstructive hypertrophic cardiomyopathy (HCM), as shown in the SCOUT-HCM trial.








